Ep. 46 Splice Bio And The Future Of Vision Loss Treatment | Gene Therapy For Stargardt Disease

In this interview, we sit down with John Tobin, Vice President of Clinical Operations at Splice Bio, to explore groundbreaking gene therapy research for Stargardt’s disease and its potential impact on the blind and visually impaired community. John shares insights into Splice Bio’s mission, how their innovative work could transform options for people living with vision loss, and what families, professionals, and supporters should know about emerging treatments. Stay tuned until the end for information on how to get involved in Splice Bio’s clinical trials. Learn more here:

www.splice.bio/clinical

Or send an email to:

Clinicaltrials@splice.bio

#SpliceBio #genetherapy #clinicaltrials